Services and technology for every stage of cell therapy delivery.

Four integrated practices, backed by a growing set of products that turn our operating experience into tools your team can use.

Our four practices

Integrated by design.

Cell therapy capability development

Site-tailored services to identify and close the gaps in a health system's or research site's cell therapy capabilities. Assessment, roadmap, build, and go-live.

Clinical trial strategy and operations

Specialized services and technology to navigate cell therapy complexity, accelerate trial timelines, and deliver high-quality execution, for sponsors and for sites.

Site operations

Best-in-class talent and processes for site business development, finance, and clinical operations, so providers achieve speed and quality as they grow.

Products

Built from the way high-volume programs actually run.

Each product packages a piece of operating know-how so that sites do not rebuild it from scratch. Products are delivered on their own or inside a broader engagement.

PAGONA Launch Point

Advanced therapy readiness and viability assessment: financial and operational clarity, accreditation readiness, and an executive roadmap. Bundled into every new site setup.

For: Health systems deciding whether and how to build

PAGONA SOP Library

A gold-standard, version-controlled library of clinical, operational, and financial SOPs organized by workstream, with a guided adoption path: governance, tailor, approve and train, sustain. Available self-serve or with tailoring and adoption support.

For: Sites launching or standardizing a program

PAGONA Payer Bridge

Support for complex payer contracting: segmentation strategy, negotiation, and member-specific single case agreement assistance for repeatable economics.

For: Sites moving from case-by-case agreements to durable contracts

PAGONA Clear Path

Coming soon

Managed service for prior authorization and financial clearance that reduces delays and payer confusion, so patients start treatment sooner.

For: Sites where access is bottlenecked at authorization
Product detail: Margin Map

Find where margin leaks. Fix the root cause.

Consult and workupApheresisCell processingLymphodepletionInfusionToxicity managementFollow-up

Billable does not mean separately reimbursable. Cell collection can be charged and coded, yet a payer may treat it as bundled into the product payment. Multiply that across every step of a CAR-T episode and a program can deliver excellent care while quietly losing money. Margin Map walks the full journey and, for each step, defines the site of care, chargeable services, codes, expected reimbursement method, payer requirements, and margin risk.

You get a clear view of achievable margin across the journey, specific operational actions tied to owners, and management targets for authorization speed, clean claims, denial rate, and net episode margin.

Not sure where to start?

Most engagements begin with Launch Point. Tell us where your program is and we will suggest the right entry point.

Talk to our team